What is Vinblastine Sulphate 10 mg?
Vinblastine Sulphate 10 mg is a chemotherapy medication primarily used in the treatment of various cancers. It contains the active ingredient Vinblastine Sulphate, a vinca alkaloid derived from the Madagascar periwinkle plant. This drug is widely prescribed due to its efficacy in managing certain types of malignancies by slowing or stopping the growth of cancer cells.
Manufactured by Cipla Limited, Vinblastine Sulphate 10 mg is an injectable formulation used under strict medical guidance. It is a critical part of many chemotherapy regimens aimed at controlling complex cancers such as breast cancer, kidney cancer, and Hodgkin’s disease. Patients in Canada and worldwide benefit from its targeted mechanism that helps improve treatment outcomes when combined with other cancer therapies.
Uses of Vinblastine Sulphate 10 mg
- Treatment of breast cancer, where targeted options such as lapatinib may also be used
- Management of kidney cancer, an area where sorafenib is also prescribed
- Therapy for Hodgkin’s lymphoma (Hodgkin’s disease)
How Vinblastine Sulphate 10 mg Works
Vinblastine Sulphate works by inhibiting the ability of cancer cells to divide and multiply. It specifically binds to tubulin, a protein essential for the formation of microtubules during cell division. By disrupting microtubule assembly, it prevents the cancer cells from proceeding through mitosis, leading to cell death.
This action makes Vinblastine Sulphate 10 mg a potent cytotoxic agent that halts tumor growth and helps to reduce the spread of cancer cells. Its mechanism is effective against rapidly dividing cells, making it valuable in chemotherapy protocols.
Benefits of Vinblastine Sulphate 10 mg
- Effective treatment of multiple cancer types
- Helps improve survival rates in cancer patients
- Targets rapidly dividing cancer cells specifically
- Used in combination therapies to enhance efficacy
- Manufactured to strict quality standards by Cipla Limited
Dosage and Administration
Vinblastine Sulphate 10 mg is administered under the supervision of an oncologist. Dosage depends on the specific cancer type, patient weight, and overall health. It is typically given by intravenous injection, ensuring precise dosing.
The treatment schedule varies per individual, with cycles allowing the patient’s normal cells to recover between doses. It is essential that patients follow their healthcare provider’s prescription and not adjust the dose without medical advice, and this vinblastine drug monograph details monitoring and dosing considerations.
Who Should Use Vinblastine Sulphate 10 mg?
Patients diagnosed with breast cancer, kidney cancer, or Hodgkin’s disease as part of their chemotherapy regimen may be prescribed Vinblastine Sulphate 10 mg. It is suitable for adults and sometimes children under specialist supervision. Its use is determined by an oncologist based on thorough diagnostic tests and overall treatment plans.
Who Should Avoid Vinblastine Sulphate 10 mg?
Individuals with a known allergy to Vinblastine Sulphate or any components of the formulation should avoid this medication. Patients with severely compromised bone marrow function or serious infections should not use this drug without close medical supervision. Pregnant or breastfeeding women must only use it if the potential benefits outweigh risks as assessed by their doctor.
Side Effects
- Hair loss
- Nausea
- Vomiting
- Constipation
- Fatigue
- Low white blood cell counts (risk of infection)
- Peripheral neuropathy (tingling or numbness in hands or feet)
- Mouth sores
- Muscle weakness
Safety Advice
- Inform your doctor about any allergies or medications you are taking
- Regular blood tests are required to monitor blood cell counts
- Avoid exposure to infections during treatment
- Report any unusual symptoms immediately to your healthcare provider
- Do not miss scheduled doses or change the dose without consulting your doctor
- Pregnant or breastfeeding women must seek specialist advice before use
Drug Interactions
- Other chemotherapy agents, including etoposide
- CYP3A4 inhibitors or inducers
- Medications affecting bone marrow function
- Immunosuppressants
- Anticonvulsants
Storage Instructions
Store Vinblastine Sulphate 10 mg in a cool, dry place away from direct sunlight. Keep the medication tightly sealed and out of reach of children. It should be stored at room temperature as per manufacturer guidelines and not frozen. Dispose of any unused parts responsibly, following healthcare facility protocols.
Where to buy Vinblastine Sulphate 10 mg in Canada?
Vinblastine Sulphate 10 mg can be purchased through licensed pharmacies and healthcare providers in Canada. It is important to obtain this medication via prescription and through reputable pharmacies to ensure safety and quality. Many hospitals and oncology centers dispense this medication as part of chemotherapy treatment plans.
Frequently Asked Questions (FAQ)
Is Vinblastine Sulphate 10 mg available in Canada?
Yes, Vinblastine Sulphate 10 mg is available in Canada through licensed healthcare facilities and pharmacies with a valid prescription.
What is the price of Vinblastine Sulphate 10 mg in Canada?
The price may vary depending on the pharmacy and healthcare provider. It is best to consult directly with your treating hospital or pharmacy for accurate pricing information.
What happens if I miss a dose?
If you miss a dose, contact your oncologist immediately for advice. Do not attempt to take a double dose to make up for the missed one.
Where can I find Vinblastine Sulphate 10 mg for sale?
Vinblastine Sulphate 10 mg is sold only with a prescription at licensed medical facilities and pharmacies in Canada. Avoid unverified online sources to ensure authenticity.
Can Vinblastine Sulphate 10 mg be used with other cancer medications?
Yes, it is often used in combination with other chemotherapy drugs such as chlorambucil as part of an oncologist's treatment plan to maximize efficacy.
Are there any special precautions during use?
Yes, frequent monitoring of blood counts and overall health is essential. Inform your healthcare provider of any side effects or infections promptly.
Can I travel while undergoing treatment with Vinblastine Sulphate 10 mg?
Travel should be discussed with your oncologist. Ensure you have access to medical care and carry all relevant treatment information when traveling.
Conclusion
Vinblastine Sulphate 10 mg is a critical therapeutic agent in the treatment of breast cancer, kidney cancer, and Hodgkin’s disease. Produced by Cipla Limited, it offers targeted action against cancer cell division, improving patient outcomes in carefully monitored chemotherapy regimens. Proper administration, vigilant monitoring, and adherence to safety guidelines make this medication a valuable option for cancer care in Canada and worldwide.
Leave A Review